Common Contracts

CERTAIN INFORMATION (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. AGREEMENT AND PLAN OF MERGER BY AND AMONG ZOGENIX, INC. XENA...

Agreement and Plan of Merger • August 26th, 2019 • Zogenix, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  August 26th, 2019
• Company
  Zogenix, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Agreement and Plan of Merger (this “Agreement”) dated as of August 23 2019, is made by and among Zogenix, Inc., a Delaware corporation (“Buyer”), Xena Merger Sub, Inc., a Delaware corporation (“Merger Sub”), a Delaware corporation and wholly-owned subsidiary of Buyer, Modis Therapeutics, Inc., a Delaware corporation (the “Company”) and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the Shareholders’ Representative.

AGREEMENT AND PLAN OF MERGER BY AND AMONG AMICUS THERAPEUTICS, INC., COLUMBUS MERGER SUB CORP., CELENEX, INC. AND SHAREHOLDER REPRESENTATIVE SERVICES LLC, AS SHAREHOLDERS’ REPRESENTATIVE DATED AS OF SEPTEMBER 19, 2018

Agreement and Plan of Merger • September 25th, 2018 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  September 25th, 2018
• Company
  Amicus Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Agreement and Plan of Merger (this “Agreement”) dated as of September 19, 2018, is made by and among Amicus Therapeutics, Inc., a Delaware corporation (“Buyer”), Columbus Merger Sub Corp., a Delaware corporation (“Merger Sub”), Celenex, Inc., a Delaware corporation (the “Company”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the Shareholders’ Representative.